In PSM’s round-up this week: HHS defies 20 years of expertise and guidance and recent negative feedback to finalize regulations for state-based Canadian drug importation programs, forward movement on the Safe Therapeutics Act, and more #covidscam and counterfeit drug news.
On September 23, 2020, Department of Health and Human Services Alex Azar submitted a letter to House Minority Leader Kevin McCarthy certifying that Canadian drug importation would pose not additional threats to consumers and would save Americans a significant amount of money on prescription drugs.
Trump Administration Defies 20 Years of FDA Expertise and Guidance in Finalizing Politically Motivated Drug Importation Rule Washington, D.C. (September 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Trump Administration’s Final Rule issued today on the importation of prescription drugs: “With 40…
On September 24th, 2020 the U.S. Department of Health and Human Services released a draft of finalized rulemaking for Importation of Prescription Drugs. Watch this space for the most up-to-date news.
Last June, police in Ontario, Canada carried out Project Javelin, shutting down a huge counterfeiting operation that manufactured hundreds of thousands of fentanyl pills disguised as Oxycocet, a Health Canada-approved generic oxycodone and acetaminophen product with the same ingredients as Percocet.
Update: Executive Director Shabbir Safdar followed up with retired Chief Superintendent of the Ontario Police Don Bell to talk about the impact these criminals could have had. Watch that interview in our September 23rd video, “Deadly Pills in Ontario.”